OBS! Ansökningsperioden för denna annonsen har
passerat.
Arbetsbeskrivning
Job description: We are looking for an experienced dry formulation specialist who knows how to create the best products. You will be responsible for developing new dosage forms, pharmaceutical compositions and techniques. You will be our expert and advisor on dry formulations, optimisation and qualification of formulations and processes on a laboratory scale. You will also act as an adviser for the younger product developers within Orexo AB. You will monitor development through industry literature, courses and conferences; produce supporting documentation for specifications regarding substances and finished products; keep records (testing plans, journal entries, technical reports, etc.), and participate in quality assurance by establishing development routines. You will also be responsible for pharmaceutical development and construction. Personal Characteristics : You are a team player and possess integrity, a sense of responsibility, commitment and loyalty. You maintain a positive attitude and have a natural ability to enthuse others. Energetic and creative are also adjectives that describe you. You enjoy the coaching and mentoring aspect of the job. Requirements: A completed technical secondary school education or university degree in pharmacy and/or chemistry. Several years experience in drug development in the pharmaceutical industry. Solid knowledge about current guidelines regarding product development and production within the pharmaceutical industry. Experience with quality assurance and quality systems such as Good Manufacturing Processes (GMP). Results-oriented and able to multi-task. Excellent communication skills. ----------------------------------------------------------------------------- Orexo is a pharmaceutical company that focuses on developing new pharmaceutical drugs within areas currently subject to considerable clinical needs. Orexo s products are based on existing pharmaceuticals and the company s patented drug-delivery technologies. Orexo applies its broad expertise in medicine and pharmacy to the further development of existing pharmaceutical substances. By combining well-documented compounds with its own patented drug-delivery methods and its unique expertise in "dry formulations" (for example, tablets), Orexo is able to develop new patented pharmaceuticals. At present, the company has two products on the market, one product submitted for registration on the European market, three in late stage clinical development - one of which has been out-licensed in the US, Europe and Japan - and two projects in pharmaceutical formulation phase. Orexo has an active intellectual property rights strategy and an extensive patent portfolio to protect its products and technologies. Orexo is listed on the OMX Nordic List Mid Cap (ticker: ORX). www.orexo.com ----------------------------------------------------------------------------